Article info
PDFEditorial commentary
A step forward towards personalised immunosuppressive therapy in neuromyelitis optica spectrum disorder
- Correspondence to Dr Ho Jin Kim, Department of Neurology, Research Institute and Hospital of National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si 410-769, Korea; hojinkim{at}ncc.re.kr
Citation
A step forward towards personalised immunosuppressive therapy in neuromyelitis optica spectrum disorder
Publication history
- Received March 6, 2017
- Accepted March 13, 2017
- First published June 12, 2017.
Online issue publication
July 13, 2017
Article Versions
- Previous version (13 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.